Prognostic value of prostate-specific antigen for women with breast cancer: A large United States cohort study

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1489-1497

  Yu, He ^a,e   Levesque, Michael A ^b,c   Clark, Gary M ^d   Diamandis, Eleftherios P ^b,c  

^a Diagnostic Systems Laboratories Inc   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BREAST CANCER; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; COHORT STUDIES; CYTOSOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PLOIDIES; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; S PHASE; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 0031778650     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Oesterling, J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907-923, 1989.
2. Partin, A. W., and Oesterling, J. E. The clinical usefulness of prostate specific antigen: update 1994. J. Urol., 152: 1358-1368, 1994.
3. Diamandis, E. P., Yu, H., and Sutherland, D. J. A. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res. Treat., 32: 291-300, 1994.
4. Yu, H., and Diamandis, E. P. Prostate specific antigen immunoreactivity in amniotic fluid. Clin. Chem., 41: 204-210, 1995.
5. Yu, H., and Diamandis, E. P. Prostate specific antigen in milk of lactating women. Clin. Chem., 41: 54-60, 1995.
6. Levesque, M. A., Yu, H., D'Costa, M., and Diamandis, E. P. Prostate specific antigen expression by various tumors. J. Clin. Lab. Anal., 9: 123-128, 1995.
7. Monne, M., Croce, C. M., Yu, H., and Diamandis, E. P. Molecular characterization of prostate-specific antigen mRNA expressed in breast tumors. Cancer Res., 41: 6344-6347, 1994.
8. Yu, H., Diamandis, E. P., Levesque, M. A., Asa, S. L., Monne, M., and Croce, C. M. Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res., 55: 1603-1606, 1995.
9. Diamandis, E. P., Yu. H., and Lopez-Otin, C. Prostate specific antigen: a new constituent of breast cyst fluid. Breast Cancer Res. Treat., 38: 259-264, 1996.
10. Levesque, M. A., Yu, H., D'Costa, M., Tadross, L., and Diamandis, E. P. Immuroreactive prostate specific antigen in lung tumors. J. Clin. Lab. Anal., 9: 375-379, 1996.
11. Yu, H., Diamandis, E. P., Levesque, M., Giai, M., Roagna R., Ponzone, R., Sismondi, P., Monne, M., and Croce, C. M. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res. Treat., 40: 171-178, 1996.
12. Pummer, K., Wirnsberger, G., Purstner, P., Stettner H., and Wandschneider, G. False positive prostate specific antigen values in the sera of women with renal cell carcinoma. J. Urol., 148: 21-23, 1992.
13. Clements, J., and Mukhtar, A. Glandular kallikreins and prostate specific antigen are expressed in the human endometnum. J. Clin. Endocrinol. Metab., 78: 1536-1539, 1994.
14. Pollen, J. J., and Dreilinger, A. Immunohistochemical identification of prostatic acid phosphatase and prostate specific antigen in female periurethral gland. Urology, 23: 303-304, 1984.
15. Papotti, M., Paties, C., Peveri, V., Moscuzza, L., and Bussolati, G. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tissues and tumors. Basic Appl. Histochem., 33: 25-29, 1989.
16. van Krieken, J. H. Prostate marker immunoreactivity in salivary gland neoplasms. Am. J. Surg. Pathol., 17: 410-414, 1993.
17. Yu H., Diamandis, E. P., Zarghami, N., and Grass, L. Induction of prostate specific antigen production by steroids and tamoxifen in the breast cancer cell lines. Breast Cancer Res. Treat., 32: 301-310, 1994.
18. Yu, H., Diamandis, E. P., Monne, M., and Croce, C. M. Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J. Biol. Chem., 270: 6615-6618, 1994.
19. Cohen, P., Graves, H. C. B., Peehl, D. M., Kamarei, M., Giudice, L. C., and Rosenfeld, R. G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found m seminal plasma. J. Clin. Endocrinol. Metab., 75: 1046-1053, 1992.
20. Cohen, P., Peehl, D. M., Graves, H. C. B., and Rosenfeld, R. G. Biological effects of prostate specific antigen as an insulin-like growth factor binding-3 protease. J. Endocrinol., 142: 407-415, 1994.
21. Yu, H., Diamandis, E. P., and Sutherland, D. J. A. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patients age. Clin. Biochem., 27: 75-79, 1994.
22. Yu, H., Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J. A., Levesque, M. A., Roagna, R., Ponzone, R., and Sismondi, P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res., 55: 2104-2110, 1995.
23. Ferguson, R. A., Yu, H., Kalyvas, M., Zammit, S., and Diamandis, E. P. Ultrasensitive detection of prostate specific antigen by a new time resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin. Chem., 42: 675-684, 1996.
24. Yu. H., and Diamandis, E. P. Ultrasensitive time-resolved immunofluorometric assay of prostate specific antigen in serum and preliminary clinical study. Clin. Chem., 39: 2108-2114, 1993.
25. Dressler, L. G., Seamer, L. C., Owens, M. A., Clark, G. M., and McGuire, W. L. DNA flow cytometry and prognostic factors in 1131 frozen breast cancer specimens. Cancer (Phila.), 61: 420-427, 1988.
26. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660-672, 1949.
27. Lowry, O. H., Roseborough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with folin-phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
28. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
29. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B, 34: 187-202, 1972.
30. Levesque, M. A., Clark, G. M., Yu, H., and Diamandis, E. P. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumors and their association with other prognostic indicators. Br. J. Cancer, 72: 720-727, 1995.
31. Muss, H. B. Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res. Treat., 21: 15-26, 1992.
32. Leygue, E. R., Watson, P. H., and Murphy, L. C. Estrogen receptor variants in normal human mammary tissue. J. Natl. Cancer Inst., 88: 284-290, 1996.
33. Figueroa, J. A., and Yee, D. The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res. Treat., 22: 81-90. 1992.
34. Rosen, N., Yee, D., Lippman, M. E., Paik, S., and Cullen, K. J. Insulin-like growth factors in human breast cancer. Breast Cancer Res. Treat., 18: S55-S56, 1991.
35. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
36. Conover, C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology, 130: 3191-3199, 1992.
37. Yu, H., Levesque, M. A., Khosravi M. J., Papanastasiou-Diamandi. A., Clark, G. M., and Diamandis, E. P. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br. J. Cancer, 74: 1242-1247, 1996.